Northwest Biotherapeutics held its annual meeting of stockholders, where they voted on various matters including the re-election of directors, ratification of appointment of registered public accounting firm, ratification of option awards, approval of executive compensation, approval of option awards to independent directors, and approval of an amendment to increase the number of authorized shares of common stock.